Daily oral administration of probiotics engineered to constantly secrete short-chain fatty acids effectively prevents myocardial injury from subsequent ischemic heart disease.

Quynh Hoa PhamThi Van Anh BuiWoo-Sup SimKing Hoo LimCarmen Oi Kwan LawWanyu TanRi Youn KimKwan Ting ChowHun-Jun ParkKiwon BanTerrence Chi Kong Lau

Published in: Cardiovascular research (2024)

These data provide strong evidence to support the use of SCFA-secreting probiotics to prevent coronary heart disease. Since SCFAs also play a key role in other metabolic diseases, EcN_TL can potentially be used to treat a variety of other diseases.

Keyphrases

fatty acid
electronic health record
physical activity
big data
machine learning
data analysis